Nicholas Company, Inc. Astrazeneca PLC Transaction History
Nicholas Company, Inc.
- $5.66 Billion
- Q3 2025
A detailed history of Nicholas Company, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Nicholas Company, Inc. holds 1,128,004 shares of AZN stock, worth $100 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
1,128,004
Previous 1,139,599
1.02%
Holding current value
$100 Million
Previous $79.6 Million
8.67%
% of portfolio
1.53%
Previous 1.39%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,465Shares Held
502MCall Options Held
7.13MPut Options Held
2.67M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.63 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.55 Billion2.42% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$3.06 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.8 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.78 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $276B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...